DigestRedComo funciona
Red
/
Empresas
Mi
No verificado

Mirum Pharmaceuticals, Inc. and Incyte

Sobre qué escribimos

BiotecnologíaFarmacéuticaHigiene alimentariaMultimediaSalud

3 Comunicados de prensa

Ver todos los comunicados de prensa
25/09/2026
Multimedia
Industria
Salud
Higiene alimentaria
Biotecnología
Medicina - Varios
Farmacéutica
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
Fuente
Mirum Pharmaceuticals, Inc. and Incyte
Editor
Business Wire
1.00
0
14/06/2026
Multimedia
Mercado laboral
Eventos
Industria
Salud
Higiene alimentaria
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva
Fuente
Mirum Pharmaceuticals, Inc. and Incyte
Editor
Business Wire
1.00
0
04/06/2026
Multimedia
Mercado laboral
Eventos
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026
Fuente
Mirum Pharmaceuticals, Inc. and Incyte
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0